Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories 1.44%102.380.8%$737.26m
TMOThermo Fisher Scientific, Inc. 0.43%419.921.0%$615.58m
MDTMedtronic Plc 1.43%102.720.6%$492.20m
ISRGIntuitive Surgical, Inc. 1.67%668.482.4%$488.76m
DHRDanaher Corp. 0.55%204.600.7%$432.52m
BDXBecton, Dickinson & Co. 0.08%221.351.0%$412.73m
QDELQuidel Corp. 1.86%195.537.7%$401.97m
INOInovio Pharmaceuticals, Inc. 7.61%16.545.9%$401.56m
DXCMDexCom, Inc. 2.82%392.807.9%$308.65m
SYKStryker Corp. 1.82%202.591.3%$279.33m
BSXBoston Scientific Corp. 0.31%37.241.0%$274.85m
VARVarian Medical Systems, Inc. 0.11%172.049.1%$269.81m
BAXBaxter International, Inc. 0.32%78.951.8%$243.50m
ALGNAlign Technology, Inc. 1.70%317.186.4%$229.36m
EWEdwards Lifesciences Corp. 2.33%76.410.4%$221.68m

Company Profile

Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. The firm's drug candidates include SynCon immunotherapies which helps break the immune system’s tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.